Note: Ingredients listed on restricted chemical lists
EC/CAS
65996-61-4
Name of the chemical
Cellulose pulp
Concentration
N/A
EC/CAS
14808-60-7
Name of the chemical
Silica, crystalline
Concentration
N/A
General Information
Revision date
2012-06-11
Product name
CS85
Manufacturer Name
BNZ Materials, Inc
Icons in SDS
Company Information
company name
BNZ Materials, Inc
Section 2
SECTION 2: Hazards identification
EMERGENCY OVERVIEW Contains crystalline silica, a chronic health hazard by inhalation. Prolonged exposure to crystalline silica dust may cause permanent and irreversible lung damage, including silicosis, and increased risk of lung cancer, kidney and liver damage. Silicosis is a rapidly progressive, non-cancerous lung disease that is often fatal. Symptoms include shortness of breath, cough, fever, weight-loss and chest pain. Crystalline silica, inhaled in the form of quartz and/or cristobalite, has been classified as a known human carcinogen (Group 1) by the International Agency for Research on Cancer (IARC), and as a suspected human carcinogen (Group 2A) by the Association of Governmental Industrial Hygienists (ACGIH).
NFPA Ratings
Health 1 Fire 0 Reactivity 0 Special Hazard 0
HMIS® ratings
Health 1 Fire 0 Reactivity 0 PPE Code E
Hazard categories
Acute (Immediate) Health Hazard; Chronic (Delayed) Health Hazard Routes of Entry Lungs and respiratory system via respirable dust (inhalation), and eyes via coarse dust and particulates. Target Organs Lungs, respiratory system, and eyes. Signs and Symptoms of Overexposure Inhalation Respirable airborne particulates may cause transitory irritation to the lungs and upper respiratory system. Symptoms of overexposure may include shortness of breath, coughing and chest pain. Skin Contact Long-term exposure to product dust may cause dryness and/or irritation. Eye Contact Product dust is a mechanical irritant which may cause moderate to severe eye irritation and dryness. Ingestion Non-hazardous when ingested. May cause mild irritation to the gastro-intestinal (GI) tract and mouth if excessive quantities are ingested.
Medical Conditions Generally Aggravated by Exposure
Medical conditions aggravated by exposure to this product include dry skin, dermatitis, and pre-existing chronic upper respiratory and lung diseases (i.e., bronchitis, Exposure emphysema and asthma). Cigarette smoking may increase the risk of silicosis, bronchitis, pneumoconiosis and lung cancer in persons exposed to crystalline silica.